In both human and experimental PAH models, many studies have shown that STAT3 hyperactivation modulates the expression of a broad range of proteins and transcription factors (i.e., NFAT, KLFs, and HIF1-α) that are implicated in PAH pathogenesis [23,44,45,46]. This evidence concerns the gene STAT3 and pulmonary arterial hypertension.